# Metabolic Surgery for Atrial Fibrillation Elimination

> **NCT07027969** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Ali Aminian** · enrollment: 100 (estimated)

## Conditions studied

- Atrial Fibrillation
- Obesity and Obesity-related Medical Conditions

## Interventions

- **PROCEDURE:** Roux-en-Y Gastric Bypass or Sleeve Gastrectomy
- **DRUG:** Anti-Obesity Medication (AOM) treatment

## Key facts

- **NCT ID:** NCT07027969
- **Lead sponsor:** Ali Aminian
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11-01
- **Primary completion:** 2029-12-31
- **Final completion:** 2030-03-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07027969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07027969, "Metabolic Surgery for Atrial Fibrillation Elimination". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07027969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*